Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1995
06/29/1995CA2178735A1 Mediators of chronic allograft rejection
06/29/1995CA2178711A1 Composition and methods to improve neural outcome
06/29/1995CA2177061A1 Dna encoding the wnt-x growth factor
06/29/1995CA2156622A1 Novel human .beta.2 integrin alpha subunit
06/29/1995CA2155098A1 Biologically active 3-substituted oxindole derivatives useful as anti-angiogenic agents
06/28/1995EP0659883A2 Protein p140 and DNA encoding it
06/28/1995EP0659766A1 Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
06/28/1995EP0659764A2 Peptides modified by the phosphine group for marking with 99mTC and 186-188Re or paramagnetic agents
06/28/1995EP0659755A1 Phospholipids as vectors for active molecules, their preparation and their use in cosmetic or dermatologic compositions
06/28/1995EP0659439A2 Immunoconjugates
06/28/1995EP0659436A1 A potentiator for interferon and an antiviral activity-potentiating composition containing interferon and its potentiator
06/28/1995EP0659408A1 Use of R(+)alpha-lipoic acid, R-(-)dihydrolipoic and metabolites for the treatment of diabetes mellitus and its resulting disorders
06/28/1995EP0659349A1 Treatment of diabetes by administration of myo-inositol
06/28/1995EP0659214A1 Allergenic proteins and peptides from japanese cedar pollen
06/28/1995EP0659213A1 Growth hormone antagonists
06/28/1995EP0659212A1 Mammamodulin, a hormone-independent mammary tumor cells specific protein
06/28/1995EP0659211A1 Methods and therapeutic compositions for treating cystic fibrosis
06/28/1995EP0659193A1 Platelet aggregation inhibitors
06/28/1995EP0659192A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans
06/28/1995EP0659191A1 Cloning and expression of pur protein
06/28/1995EP0659184A1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof.
06/28/1995EP0659181A1 Sulfonamide inhibitors of hiv-aspartyl protease
06/28/1995EP0659179A1 Benzo-fused lactams promote release of growth hormone
06/28/1995EP0659175A1 Optically active alkylammonium (amino-3 phenyl)-1 ethanesulfonate derivatives, preparation and use thereof.
06/28/1995EP0659085A1 Method of inhibiting cell proliferation using apolipoprotein e
06/28/1995EP0659084A1 Medical preparations containing n-methylated cyclic undecapeptides.
06/28/1995EP0659083A1 Prevention and treatment of peripheral neuropathy
06/28/1995EP0659082A1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine
06/28/1995EP0642350A4 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties.
06/28/1995EP0640095A4 Process for making vancomycin.
06/28/1995EP0563256B1 Use of host cell phospholipids for inhibiting bacterial colonization
06/28/1995EP0513073B1 PROCESS FOR ENZYMATICAL CLEAVAGE OF RECOMBINANT PROTEINS BY MEANS OF IgA PROTEASES
06/28/1995EP0494268B1 Method for inhibiting growth of stem cells
06/28/1995EP0465556B1 Platelet specific immunoconjugates
06/28/1995EP0460171B1 Cd3 specific recombinant antibody
06/28/1995EP0457758B1 Tissue plasminogen activator having zymogenic or fibrin specific properties
06/28/1995EP0439540B1 Antibody conjugates with two or more covalently linked fc regions
06/28/1995EP0432220B1 Vaccines and diagnostic assays for haemophilus influenzae
06/28/1995CN1104217A Peptides having T cell helper activity
06/28/1995CN1104121A Carious-tooth resistant compound and its preparation method
06/28/1995CN1029131C Process for transforming human insulin precarsor to human insulin
06/28/1995CA2139014A1 Phospholipids comprising an active molecule, their preparation and their use in cosmetic or dermatologic compositions
06/27/1995US5428158 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/27/1995US5428143 A chimeric gene which encodes a hybrid protein capable of binding to an HIV infected cell
06/27/1995US5428135 Production of platelet-derived growth factor B-chain heterodimers from high expression host cell system
06/27/1995US5428133 Chimeric anti-human IgE-monoclonal antibody which binds to secreted IgE and membrane-bound IgE expressed by IgE-expressing B cells but notto IgE bound to FC receptors on basophils
06/27/1995US5428130 Cell surface adhesion molecules and ligands
06/27/1995US5428070 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
06/27/1995US5428024 High concentration homogenized collagen compositions
06/27/1995US5428023 Oral delivery of biologically active substances bound to vitamin B12 or analogues thereof
06/27/1995US5428022 For augmenting soft tissue; cosmetic defects
06/27/1995US5428021 Human leukocyte elastase (HLE) inhibitors, and related pharmaceutical compositions and methods of use
06/27/1995US5428020 Cysteine (NPYS)-containing peptides and use thereof for inhibiting platelet aggregation
06/27/1995US5428019 Bombesin analogs
06/27/1995US5428018 Phenylalanine analogs of bombesin
06/27/1995US5428016 Having atleast one amidated C-terminal or an acetylated N-terminal, and containing 5,6 or 11 amino acid residues
06/27/1995US5428015 Vasoactive intestinal polypeptide analogues and use thereof
06/27/1995US5428013 Differential diagnosis and treatment of the states of growth hormone insufficiency (or deficiency) with an alpha-2-adrenergic agonist and a growth hormone releasing peptide
06/27/1995US5428012 Oncostatin M and novel compositions having anti-neoplastic activity
06/27/1995US5428011 Human seminal prostate inhibin in combination with anticancer drug
06/27/1995US5428010 Biologically active B-chain homodimers
06/27/1995US5428009 Lipopeptide derivatives
06/27/1995US5428008 Comprising glycoproteins and phospholipids
06/27/1995US5428007 Increasing oxygenation in hypoxic cells of normal and tumor tissue
06/27/1995US5428006 Including an n-glycofurol; improves absorption through mucous membranes
06/27/1995US5427958 Detecting presence of autoantibodies in biological fluids; forming peptide complexes; in vitro; diagnosing lupus, autoimmune diseases
06/27/1995US5427954 Detection of aggrecan by-products
06/27/1995US5427942 Human D5 dopamine recepltor gene and uses
06/27/1995US5427939 Expression vectors encoding alloantigens of glycoprotein Ibα
06/27/1995US5427937 Hookworm anticoagulant
06/27/1995US5427927 Modifying junction region between two components of fusion protein to form immunoglobulin A protease recognition site, cleaving, isolating component
06/27/1995US5427926 Anticoagulant; sulfated glycoprotein
06/27/1995US5427925 Recombniant method for making leukemia inhibitor factor
06/27/1995US5427919 Hydrolytic enzyme inhibitors/inactivators and methods for using same
06/27/1995US5427918 Incubating plasminogen activator with fibrinogen degradation product containing methionine oxidized to sulfoxide; chromatography
06/27/1995US5427797 Anticoagulants; therapy for respiratory system disorders
06/27/1995US5427792 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the E1 and E2 protein of rubella virus
06/27/1995US5427781 Administering in conjunction with chemotherapeutic agents
06/27/1995US5427778 Gel formulations containing growth factors and acrylamide polymer
06/27/1995US5427769 Contacting teeth with food containing milk isolated micellar casein to inhibit oral streptococcus sobrinus growth
06/27/1995CA1336119C Vinca derivative conjugates containing a c-3 detergent chain
06/27/1995CA1336048C Process for making flexographic plates with increased flexibility
06/23/1995CA2137431A1 Treatment of diabetes by administration of myo-inositol
06/22/1995WO1995016915A1 METHODS AND MATERIALS FOR THE DETECTION OF $i(STAPHYLOCOCCUS AUREUS)
06/22/1995WO1995016784A1 Human interferon expression vectors for treating aids
06/22/1995WO1995016780A1 Antiviral composition of viral protein trans-dominant variants
06/22/1995WO1995016777A1 Purification of insulin-like growth factor
06/22/1995WO1995016710A1 Specific hyperimmune anti-hiv globulin for passive immunization
06/22/1995WO1995016709A2 Anti-mullerian hormone receptor polypeptides and antibodies thereto
06/22/1995WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
06/22/1995WO1995016706A1 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
06/22/1995WO1995016705A1 Vpr receptor protein
06/22/1995WO1995016704A1 Hepatitis b virus peptides
06/22/1995WO1995016703A1 Igf-1 analogs
06/22/1995WO1995016702A1 Peptide inhibitors of cxc intercrine molecules
06/22/1995WO1995016694A1 Origin of replication complex genes, proteins and methods
06/22/1995WO1995016675A1 Benzo-fused lactams promote release of growth hormone
06/22/1995WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation
06/22/1995WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy
06/22/1995WO1995016462A1 Method for antigen-specific immunoregulation by t-cell alpha chain
1 ... 2840 2841 2842 2843 2844 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 ... 3163